Skip to main content
glpverdict
Editorial medical reviewFDA & peer-reviewed sourcesUpdated weeklyMedically reviewed content

Saxenda reference

What to do if you miss a Saxenda dose

Daily injection. If missed >12 hours, skip the dose and resume the next day at the regular time. Never double up.

Detailed guidance

  • Daily — same time each day if possible.
  • Missed <12 hours: take immediately.
  • Missed >12 hours: skip, resume next day.
  • Off therapy ≥3 days requires re-titration from 0.6 mg.

Source: Saxenda FDA prescribing information (opens in a new tab)

People also ask

Common questions readers ask

Can GLP-1 cause thyroid cancer?
The boxed warning is based on rodent studies showing medullary thyroid carcinoma (MTC) in mice and rats. No human cases have been attributed to GLP-1 use despite 10+ years post-approval surveillance.
Full evidence-graded answer
Do GLP-1 medications affect mood or depression?
Mixed evidence. The FDA label has a precaution but no boxed warning. Some patients report improved mood (likely from weight loss + glycemic control); a smaller subset reports increased anxiety or low mood, especially in early weeks. Pre-existing depression history is a flag for closer monitoring.
Full evidence-graded answer
How do you store GLP-1 pens?
Refrigerate unopened pens at 36-46°F (2-8°C) until first use. Once started, room temperature ≤86°F (30°C) is fine for up to 28 days. Never freeze; never store in direct sunlight; do not store in checked luggage.
Full evidence-graded answer
How do you inject a GLP-1 safely?
Rotate sites between abdomen (≥2 inches from navel), front of thigh, and back of upper arm. Inject at room temperature (cold pens sting). Pinch a fold of skin, insert at 90°, hold 6 seconds after the click, withdraw straight. Dispose in a sharps container.
Full evidence-graded answer
How does Wegovy compare to Saxenda?
Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.
Full evidence-graded answer

Next step

See the full Saxenda drug profile — efficacy, side effects, cost, and provider options.

See full Saxenda profile

Editorial information based on FDA prescribing data. Not personal medical advice. For urgent symptoms call your prescriber or 911.